On November 26, 2019 Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, reported that it will be presenting at the Evercore ISI HealthCONx conference on Wednesday, December 4, 2019 at 2:20 PM ET / 11:20 AM PT at the Four Seasons Hotel in Boston (Press release, Savara, NOV 26, 2019, https://savara.gcs-web.com/news-releases/news-release-details/savaras-coo-and-cmo-present-evercore-isi-2nd-annual-healthconx [SID1234551757]). Taneli Jouhikainen, Savara’s President and Chief Operating Officer, and Badrul Chowdhury, Savara’s Chief Medical Officer, will participate in a fireside chat at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interested parties can access a live audio webcast of the fireside chat on the Investors page of the Savara website at www.savarapharma.com/investors/events-presentations/. An archived presentation will be available on Savara’s website for 90 days following the event.